Hospital-based HIV/HSV-2 seroprevalence among male patients with anal disease in Korea: cross sectional study

BMC Infectious Diseases

Table 2 HIV seroprevalence and HSV-2 seroprevalence by age among male patients with anal disease, 2009

Age	No. (%)	HIV +^a	HIV seroprevalence per 10000	HSV-2 +^b	HSV-2 seroprevalence (%)
Total	2,038 (100)	5	24.5	489	24.0
< 20	37 (1.8)	0	0	2	5.4
20–29	224 (11.0)	3	134	18	8.0
30–39	446 (21.9)	1	22	52	11.7
40–49	398 (19.5)	1	25	85	21.4
50–59	477 (23.4)	0	0	166	34.8
≥ 60	456 (22.4)	0	0	166	36.4

HIV seroprevalence was defined as the number of confirmed HIV cases per 10,000 of HIV-tested people.
HSV-2 seroprevalence was defined as the proportion of HSV-2-positive people. The 2,038 HSV-2 samples randomly selected among 26,173 male patients with anal disease tested for HIV in 2009.
^aHIV+: the number of HIV-infected individuals.
^bHSV2: the number of HSV-2-infected individuals.

ISSN: 1471-2334